Danish Drugmaker Leo Pharma Is Said to Seek Bank Pitches for IPO

Leo Pharma A/S has invited investment bankers to vie for roles in a potential initial public offering, according to people familiar with the matter, as the more-than-a-century-old Danish drugmaker edges closer to going public.

The company, which focuses on skin conditions, is considering Copenhagen as a possible listing venue, said the people, who asked not to be identified as the information is private. Deliberations are ongoing and no final decisions have been made, the people said.

“LEO Pharma has been open about preparing for a possible future IPO, but we have no further comments on the process beyond this,” Jeppe ...